Fundai

Zahravi Pharmaceutical Company (DZAHRAVI) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DZAHRAVI
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations256,492-155,1372,8051,014,024525,570564,208
Cash payments for income tax-317,252-101,567-130,227-83,817-19,127-22,653
Net cash inflow (outflow) from operating activities-60,760-256,704-127,422930,207506,443541,555
Cash payments for purchase of property, plant and equipment-113,738-37,302-23,798-18,764-17,616-14,579
Cash payments for purchase of intangible assets-18,00000000
Cash receipts from interest on other investments2,62633923,0326147355,045
Net cash inflow (outflow) from investing activities-129,112-36,963-766-18,150-16,885-9,534
Net cash inflow (outflow) before financing activities-189,872-293,667-128,188912,057489,558532,021
Cash receipts from sale of treasury shares93,7662,94489725,10725,0633,526
Cash payments for purchase of treasury shares-89,106-2,004-16,376-27,533-23,892-67,680
Cash receipts from facilities7,014,7192,099,2581,155,9112,053,0391,681,344906,387
Cash payments for principal of loans-4,055,962-1,327,829-624,997-2,641,058-1,588,614-915,766
Cash payments for interest on loans-496,159-178,565-246,187-275,828-436,810-433,422
Cash payments for dividends-165,4210000-17,385
Net cash inflow (outflow) from financing activities2,301,837593,804269,248-866,273-342,909-524,340
Net increase (decrease) in cash2,111,965300,137141,06045,784146,6497,681
Cash balance at beginning of year693,406230,293202,319183,221149,741173,988
Effect of changes in exchange rates28,9822,23713,004693598-258
Cash balance at end of year2,834,353532,667356,383229,698296,988181,411

Reporting periods

68 periods are on file for this report, from the period ending 1388/03/31 to the period ending 1405/06/31.